BioCentury | Aug 16, 2018
Distillery Therapeutics

Infectious disease

...Inc. could include testing the compound in animal models of HCV. ContraVir Pharmaceuticals Inc. has CRV431...
BioCentury | Aug 12, 2017
Product Development

HBV test kitchen

...and CD8 T cell booster HepTcell (Ph I) 1 ContraVir Pharmaceuticals Inc. (NASDAQ:CTRV) Cyclophilin inhibitor CRV431...
BioCentury | Dec 1, 2016
Product R&D

De-stressing about NASH

...anti-infectives, in addition to immunosuppression with ciclosporin. These include ContraVir Pharmaceuticals Inc. ’s preclinical compounds CRV431...
Items per page:
1 - 3 of 3